The cannabis compound cannabidiol (CBD) may be useful in fighting methicillin-resistant Staphylococcus aureus (MRSA), according to a new peer-reviewed study.
The study, conducted by researchers at Wuyi University in China and the University of Rhode Island in the US, is being published in the December issue of the journal Bioorganic Chemistry. It’s been epublished online ahead of print.
“Drug-resistant bacterium infections are a severe threat to public health and novel antimicrobial agents combating drug-resistant bacteria are an unmet medical need”, states the study. “Although cannabidiol (CBD) has been reported to show antibacterial effects, whether its antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) can be improved remains unclear.”